Itau Unibanco Holding S.A.’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.8K | Sell |
168
-2
| -1% | -$652 | ﹤0.01% | 239 |
|
|
2025
Q1 | $46K | Sell |
170
-1
| -0.6% | -$271 | ﹤0.01% | 244 |
|
|
2024
Q4 | $40.2K | Sell |
171
-137
| -44% | -$32.2K | ﹤0.01% | 292 |
|
|
2024
Q3 | $84.7K | Sell |
308
-19
| -6% | -$5.23K | ﹤0.01% | 153 |
|
|
2024
Q2 | $79.5K | Buy |
+327
| New | +$79.5K | ﹤0.01% | 148 |
|
|
2024
Q1 | – | Sell |
-693
| Closed | -$133K | – | 110 |
|
|
2023
Q4 | $133K | Buy |
693
+85
| +14% | +$16.3K | ﹤0.01% | 166 |
|
|
2023
Q3 | $108K | Sell |
608
-2
| -0.3% | -$354 | ﹤0.01% | 180 |
|
|
2023
Q2 | $116K | Buy |
610
+40
| +7% | +$7.6K | 0.01% | 210 |
|
|
2023
Q1 | $114K | Sell |
570
-3
| -0.5% | -$601 | 0.01% | 218 |
|
|
2022
Q4 | $136K | Sell |
573
-228
| -28% | -$54.2K | 0.01% | 242 |
|
|
2022
Q3 | $160K | Sell |
801
-144
| -15% | -$28.8K | 0.01% | 253 |
|
|
2022
Q2 | $138K | Sell |
945
-58
| -6% | -$8.47K | ﹤0.01% | 250 |
|
|
2022
Q1 | $164K | Buy |
1,003
+7
| +0.7% | +$1.15K | ﹤0.01% | 220 |
|
|
2021
Q4 | $170K | Buy |
996
+250
| +34% | +$42.7K | 0.01% | 166 |
|
|
2021
Q3 | $141K | Buy |
746
+149
| +25% | +$28.2K | 0.01% | 157 |
|
|
2021
Q2 | $101K | Buy |
+597
| New | +$101K | 0.01% | 135 |
|
|
2019
Q4 | – | Sell |
-166
| Closed | -$12K | – | 855 |
|
|
2019
Q3 | $12K | Hold |
166
| – | – | ﹤0.01% | 272 |
|
|
2019
Q2 | $12K | Sell |
166
-189
| -53% | -$13.7K | ﹤0.01% | 582 |
|
|
2019
Q1 | $25K | Hold |
355
| – | – | ﹤0.01% | 555 |
|
|
2018
Q4 | $25K | Sell |
355
-182
| -34% | -$12.8K | ﹤0.01% | 555 |
|
|
2018
Q3 | $47K | Buy |
+537
| New | +$47K | ﹤0.01% | 546 |
|
|
2018
Q1 | – | Sell |
-191
| Closed | -$24K | – | 570 |
|
|
2017
Q4 | $24K | Buy |
191
+36
| +23% | +$4.52K | ﹤0.01% | 482 |
|
|
2017
Q3 | $58K | Sell |
155
-456
| -75% | -$171K | ﹤0.01% | 564 |
|
|
2017
Q2 | $49K | Buy |
611
+558
| +1,053% | +$44.8K | 0.01% | 291 |
|
|
2017
Q1 | $3K | Buy |
+53
| New | +$3K | ﹤0.01% | 671 |
|